|
市場調査レポート
商品コード
1611209
CRISPRとCas遺伝子の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030 |
||||||
カスタマイズ可能
|
|||||||
価格
| CRISPRとCas遺伝子の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年 |
|
出版日: 2024年11月21日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
CRISPRとCas遺伝子市場の成長と動向
Grand View Research, Inc.の新しいレポートによると、世界のCRISPRとCas遺伝子市場規模は2030年までに113億3,000万米ドルに達し、2025～2030年のCAGRは16.12％で成長すると予測されています。
原核生物の診断や進化分析の評価におけるCRISPR-Casシステムの使用は、ゲノム編集セグメントの開発により著しく増加しています。この技術の応用により、簡単かつ低コストで遺伝子の編集が可能になりました。ゲノム編集は生物医療研究において大きな進歩を遂げ、現在の最先端技術の動向は、さまざまな遺伝的と非遺伝的疾患の将来の治療への道を開いています。
CRISPR/Cas9を介した遺伝子とゲノム編集技術の利用が可能になったことで、遺伝子ターゲティングのためのより効果的な方法の開発と実施、遺伝子編集鳥類の作出が容易になりました。2021年2月にFrontiersに掲載された紙製によると、CRISPR/Cas9は家禽産業における遺伝子編集のための強固で重要なツールとなっています。いくつかのセグメントでの応用の可能性は、この技術の需要をさらに押し上げると考えられます。COVID-19の発生は、研究者の重点をこの技術によるCOVID-19分子診断ツールの開発にシフトさせました。例えば、2021年3月、シンガポールの南洋理工大学の研究者たちは、CRISPRに基づき、30分で結果が得られるCOVID-19検査を作成しました。
ウイルスが変異した後でも、このテストはウイルスを発見します。このことは、他の主要企業がこの技術を活用することをさらに促し、産業の成長を促進することになると考えられます。この技術は、医療やその他の用途にますます使用されるようになっています。このような遺伝子編集技術の特許をめぐる競合は、この技術の新たな商業的応用を開発しようとする学術機関やバイオテクノロジー企業が増えるにつれて、拡大していくと予想されます。さらに、機械学習技術の利用によってこの技術が進歩する可能性も大いにあります。例えば、2022年8月、Synthego社は、機能スクリーニング実験に直接使用できるようにCRISPRで編集された細胞をアレイ化することで、CRISPRへのアクセスを拡大する最先端のサービス、Engineered cell librariesを開始しました。
疾患研究への応用が期待されます。主要企業は、遺伝子編集ワークフローの各段階に対応したツールやソリューションを提供しています。複数のツール、サービス、改善されたプロセスを統合することで、研究実験を迅速かつ少ない労力で完了することが可能になります。さらに、主要企業はCRISPR &Cas9遺伝子編集アプローチの研究開発を支援するために多額の資金を調達しています。例えば、2021年4月、Vertex PharmaceuticalsはCRISPR Therapeuticsと提携し、輸血依存性βサラセミアと鎌状赤血球症（SCD）の治療選択肢となり得るCTX001と呼ばれるCRISPR/Cas9ベースの新しい遺伝子編集療法を開発・製造しました。2020年1月、Mammoth Biosciencesは、治療・診断目的の次世代CRISPR製品を開発するため、4,500万米ドルを調達しました。これはさらに、同社のCRISPR遺伝子主導型診断ポートフォリオを開発するために使用されます。
CRISPRとCas遺伝子市場レポートハイライト
- 製品・サービス別では、製品セグメントが2024年に産業を支配し、77.39%の最高シェアを占めました。
- バイオメディカルセグメントが2024年の産業を支配。ゲノム編集の先端技術を利用した広範な調査と研究件数の大幅な増加が、このセグメントの成長に寄与しています。
- バイオテクノロジーと製薬企業が2024年の市場を独占し、全体の収益シェアの49.56％を占めました。主要企業は、ヒト疾患の生物学的モデルを作製し、新たな治療標的同定をさらに加速するためにこの技術を採用しています。
- 北米が市場を独占し、2024年には41.36%の最高収益シェアを占めました。これは、複数の製薬大手の存在、研究資金の増加、研究承認の多さ、新規治療の必要性によるものです。
目次
第1章 調査手法と範囲
第2章 エグゼクティブサマリー
第3章 市場の変数、動向、範囲
- 市場系統の展望
- 親市場の展望
- 関連/補助市場展望
- 市場力学
- 市場促進要因分析
- 市場抑制要因分析
- 産業分析ツール
- ポーターのファイブフォース分析
- PESTEL分析
- COVID-19の影響分析
第4章 製品・サービスビジネス分析
- 製品・サービスセグメントダッシュボード
- 世界のCRISPRとCAS遺伝子市場：製品・サービス変動分析
- 世界のCRISPRとCAS遺伝子市場の規模と動向分析、製品・サービス別、2018～2030年
- 製品
- 製品市場、2018～2030年
- キットと試薬
- ライブラリー
- デザインツール
- 抗体
- その他
- サービス
- サービス市場、2018～2030年
- 細胞株エンジニアリング
- gRNAの設計と合成
- スクリーニングサービス
- その他
第5章 用途ビジネス分析
- 用途セグメントダッシュボード
- 世界のCRISPRとCAS遺伝子市場：用途変動分析
- 世界のCRISPRとCAS遺伝子市場の規模と動向分析、用途別、2018～2030年
- バイオメディカル
- バイオメディカル市場、2018～2030年
- ゲノム工学
- 疾患モデル研究
- 機能ゲノミクス
- エピジェネティクス
- その他
- 農業
- 農業市場、2018～2030年
第6章 最終用途ビジネス分析
- 最終用途セグメントダッシュボード
- 世界のCRISPRとCAS遺伝子市場：最終用途変動分析
- 世界のCRISPRとCAS遺伝子市場の規模と動向分析、最終用途別、2018～2030年
- バイオテクノロジーと製薬会社
- バイオテクノロジーと製薬会社市場、2018～2030年
- 学術・政府研究機関
- 学術・政府研究機関市場、2018～2030年
- 契約研究機関（CRO）
- 契約研究機関（CRO）市場、2018～2030年
- その他
- その他市場、2018～2030年
第7章 地域ビジネス分析
- 地域ダッシュボード
- 市場規模と予測と動向分析、2018～2030年
- 北米
- 北米のCRISPRとCAS遺伝子市場、2018～2030年
- 米国
- カナダ
- メキシコ
- 欧州
- 欧州のCRISPRとCAS遺伝子市場、2018～2030年
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
- アジア太平洋
- アジア太平洋のCRISPRとCAS遺伝子市場、2018～2030年
- 日本
- 中国
- インド
- 韓国
- オーストラリア
- タイ
- ラテンアメリカ
- ラテンアメリカのCRISPRとCAS遺伝子市場、2018～2030年
- ブラジル
- アルゼンチン
- 中東・アフリカ
- 中東・アフリカのCRISPRとCAS遺伝子市場、2018～2030年
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート
第8章 競合情勢
- 参入企業
- 戦略マッピング
- 企業市況分析、2024年
- 企業プロファイル/上場企業
- Thermo Fisher Scientific
- Illumina
- Agilent Technologies
- Synthego
- Danaher
- Origene Technologies
- GenScript
- Lonza
- Revvity, Inc.
- Merck KGaA
図表
List of Tables
- Table 1 List of abbreviations
- Table 2 Global CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 3 Global CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 4 Global CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 5 Global CRISPR and Cas genes market, by region, 2018 - 2030 (USD Million)
- Table 6 North America CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
- Table 7 North America CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 8 North America CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 9 North America CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 10 U.S. CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 11 U.S. CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 12 U.S. CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 13 Canada CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 14 Canada CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 15 Canada CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 16 Mexico CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 17 Mexico CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 18 Mexico CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 19 Europe CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
- Table 20 Europe CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 21 Europe CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 22 Europe CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 23 Germany CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 24 Germany CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 25 Germany CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 26 UK CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 27 UK CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 28 UK CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 29 France CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 30 France CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 31 France CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 32 Italy CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 33 Italy CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 34 Italy CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 35 Spain CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 36 Spain CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 37 Spain CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 38 Denmark CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 39 Denmark CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 40 Denmark CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 41 Sweden CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 42 Sweden CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 43 Sweden CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 44 Norway CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 45 Norway CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 46 Norway CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 47 Asia Pacific CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
- Table 48 Asia Pacific CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 49 Asia Pacific CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 50 Asia Pacific CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 51 China CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 52 China CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 53 China CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 54 Japan CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 55 Japan CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 56 Japan CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 57 India CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 58 India CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 59 India CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 60 Australia CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 61 Australia CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 62 Australia CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 63 Thailand CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 64 Thailand CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 65 Thailand CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 66 South Korea CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 67 South Korea CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 68 South Korea CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 69 Latin America CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
- Table 70 Latin America CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 71 Latin America CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 72 Latin America CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 73 Brazil CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 74 Brazil CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 75 Brazil CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 76 Argentina CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 77 Argentina CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 78 Argentina CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 79 Middle East and Africa CRISPR and Cas genes market, by country, 2018 - 2030 (USD Million)
- Table 80 Middle East and Africa CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 81 Middle East and Africa CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 82 Middle East and Africa CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 83 South Africa CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 84 South Africa CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 85 South Africa CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 86 Saudi Arabia CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 87 Saudi Arabia CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 88 Saudi Arabia CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 89 UAE CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 90 UAE CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 91 UAE CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
- Table 92 Kuwait CRISPR and Cas genes market, by product & service, 2018 - 2030 (USD Million)
- Table 93 Kuwait CRISPR and Cas genes market, by application, 2018 - 2030 (USD Million)
- Table 94 Kuwait CRISPR and Cas genes market, by end use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value chain-based sizing & forecasting
- Fig. 6 Market formulation & validation
- Fig. 7 CRISPR and Cas genes market segmentation
- Fig. 8 Market snapshot
- Fig. 9 Market trends & outlook
- Fig. 10 Market driver relevance analysis (current & future impact)
- Fig. 11 Market restraint relevance analysis (current & future impact)
- Fig. 12 PESTEL analysis
- Fig. 13 Porter's five forces analysis
- Fig. 14 Global CRISPR and Cas genes market: Product & service movement analysis
- Fig. 15 Global CRISPR and Cas genes market, for product, 2018 - 2030 (USD Million)
- Fig. 16 Global CRISPR and Cas genes market, for kits & enzymes, 2018 - 2030 (USD Million)
- Fig. 17 Global CRISPR and Cas genes market, for Cas proteins & enzymes, 2018 - 2030 (USD Million)
- Fig. 18 Global CRISPR and Cas genes market, for guide RNA, 2018 - 2030 (USD Million)
- Fig. 19 Global CRISPR and Cas genes market, for others, 2018 - 2030 (USD Million)
- Fig. 20 Global CRISPR and Cas genes market, for libraries, 2018 - 2030 (USD Million)
- Fig. 21 Global CRISPR and Cas genes market, for design tool, 2018 - 2030 (USD Million)
- Fig. 22 Global CRISPR and Cas genes market, for antibodies , 2018 - 2030 (USD Million)
- Fig. 23 Global CRISPR and Cas genes market, for other products, 2018 - 2030 (USD Million)
- Fig. 24 Global CRISPR and Cas genes market, for service, 2018 - 2030 (USD Million)
- Fig. 25 Global CRISPR and Cas genes market, for cell line engineering , 2018 - 2030 (USD Million)
- Fig. 26 Global CRISPR and Cas genes market, for gRNA design & synthesis, 2018 - 2030 (USD Million)
- Fig. 27 Global CRISPR and Cas genes market, for screening services, 2018 - 2030 (USD Million)
- Fig. 28 Global CRISPR and Cas genes market, for other services, 2018 - 2030 (USD Million)
- Fig. 29 Global CRISPR and Cas genes market: Application movement analysis
- Fig. 30 Global CRISPR and Cas genes market, for biomedical , 2018 - 2030 (USD Million)
- Fig. 31 Global CRISPR and Cas genes market, for genome engineering, 2018 - 2030 (USD Million)
- Fig. 32 Global CRISPR and Cas genes market, for disease model studies, 2018 - 2030 (USD Million)
- Fig. 33 Global CRISPR and Cas genes market, for functional genomics, 2018 - 2030 (USD Million)
- Fig. 34 Global CRISPR and Cas genes market, for epigenetics, 2018 - 2030 (USD Million)
- Fig. 35 Global CRISPR and Cas genes market, for other biomedical applications, 2018 - 2030 (USD Million)
- Fig. 36 Global CRISPR and Cas genes market, for agricultural , 2018 - 2030 (USD Million)
- Fig. 37 Global CRISPR and Cas genes market: End Use movement analysis
- Fig. 38 Global CRISPR and Cas genes market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
- Fig. 39 Global CRISPR and Cas genes market, for academic & government research institutes, 2018 - 2030 (USD Million)
- Fig. 40 Global CRISPR and Cas genes market, for Contract Research Organizations (CROs), 2018 - 2030 (USD Million)
- Fig. 41 Global CRISPR and Cas genes market, for other end use, 2018 - 2030 (USD Million)
- Fig. 42 Regional outlook, 2024 & 2030
- Fig. 43 North America CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 44 U.S. CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 45 Canada CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 46 Mexico CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 47 Europe CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 48 Germany CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 49 UK CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 50 France CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 51 Italy CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 52 Spain CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 53 Denmark CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 54 Sweden CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 55 Norway CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 56 Asia Pacific CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 57 Japan CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 58 China CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 59 India CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 60 Australia CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 61 Thailand CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 62 South Korea CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 63 Latin America CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 64 Brazil CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 65 Argentina CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 66 MEA CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 67 South Africa CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 68 Saudi Arabia CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 69 UAE CRISPR and Cas genes market, 2018 - 2030 (USD Million)
- Fig. 70 Kuwait CRISPR and Cas genes market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-375-1
CRISPR And Cas Genes Market Growth & Trends:
The global CRISPR and Cas genes market size is expected to reach USD 11.33 billion by 2030, growing at a CAGR of 16.12% from 2025 to 2030, according to a new report by Grand View Research, Inc. The use of CRISPR-Cas systems in diagnostics and the assessment of evolutionary analysis in prokaryotes has significantly increased, owing to the developments in the field of genome editing. The application of this technology enables easy and cost-efficient editing of genes. Genome editing has made a significant advancement in biomedical research, with the present trend of cutting-edge techniques paving the way for the future treatment of different genetic and non-genetic disorders.
The development and implementation of more effective ways for gene targeting and the generation of gene-edited avian species have been facilitated by the availability of the CRISPR/Cas9-mediated gene and genome editing technology. According to an article published on Frontiers in February 2021, CRISPR/Cas9 has become a robust and important tool for gene editing in the poultry industry. Potential applications in several fields would further boost the demand for this technology. The COVID-19 outbreak shifted the researcher's emphasis to the development of COVID-19 molecular diagnostic tools based on this technology. For instance, in March 2021, Nanyang Technological University researchers in Singapore created a COVID-19 test based on CRISPR that provides results in 30 minutes.
Even after the virus has mutated, this test still discovers it. This would further encourage the other key players to leverage this technique, thereby driving the industry's growth. This technology is increasingly being used for several medical and other applications. Competition over patents for such a gene-editing technology is expected to grow, as more academic institutions and biotech companies attempt to develop new commercial applications of this technology. In addition, there is a lot of potential for this technique to advance with the use of machine learning technologies. For instance, in August 2022, Synthego launched engineered cell libraries, a cutting-edge service that expands access to CRISPR by giving arrayed CRISPR-edited cells for use directly in functional screening experiments.
It has potential applications in disease research. Key players offer tools and solutions for each step of the gene editing workflow. Integrating several tools, services, and improved processes makes it possible to complete research experiments rapidly and with little effort. Moreover, key players have raised significant funding to support the R&D of the CRISPR & Cas9 gene-editing approach. For instance, in April 2021, Vertex Pharmaceuticals collaborated with CRISPR Therapeutics to develop and manufacture a new CRISPR/Cas9-based gene editing therapy called CTX001, a potential therapeutic option for transfusion-dependent beta-thalassemia and Sickle Cell Disease (SCD). In January 2020, Mammoth Biosciences raised USD 45 million to develop next-gen CRISPR products for therapeutics & diagnostics purposes. This would further be used to develop the company's CRISPR genes-driven diagnostics portfolio.
CRISPR And Cas Genes Market Report Highlights:
- By product and services, the product segment dominated the industry in 2024 and accounted for the highest share of 77.39%
- The biomedical segment dominated the industry in 2024. Extensive research and a significant rise in the number of research studies utilizing the advanced technique for genome editing have contributed to the segment growth
- The biotechnology and pharmaceutical companies dominated the market in 2024, accounting for 49.56% of overall revenue share. Key players are adopting this technology to produce biological models for human diseases and further accelerate new therapeutic target identification
- North America dominated the market and accounted for the highest revenue share of 41.36% in 2024 owing to the presence of several pharmaceutical giants, increased research funding, a high number of research approvals, and the need for novel therapeutics
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product & Service Segment
- 1.2.2. Application Segment
- 1.2.3. End Use Segment
- 1.3. Information Analysis
- 1.3.1. Market Formulation & Data Visualization
- 1.4. Data Validation & Publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing Need For Novel Therapeutics
- 3.2.1.2. Rising Demand For Gene Editing
- 3.2.1.3. Rising Incidence Of Cancer
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Off-Target Effects Of CRISPR Technology
- 3.2.2.2. High Cost Factor, Intellectual Property Disputes & Ethical Dilemma
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Product & Service Business Analysis
- 4.1. Product & Service Segment Dashboard
- 4.2. Global CRISPR And CAS Genes Market: Product & Service Movement Analysis
- 4.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
- 4.4. Products
- 4.4.1. Products Market, 2018 - 2030 (USD Million)
- 4.4.2. Kits & Reagents
- 4.4.2.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
- 4.4.2.2. Cas Proteins & Enzymes
- 4.4.2.2.1. Cas Proteins & Enzymes Market, 2018 - 2030 (USD Million)
- 4.4.2.3. Guide RNA
- 4.4.2.3.1. Guide RNA Market, 2018 - 2030 (USD Million)
- 4.4.2.4. Others
- 4.4.2.4.1. Others Market, 2018 - 2030 (USD Million)
- 4.4.3. Libraries
- 4.4.3.1. Libraries Market, 2018 - 2030 (USD Million)
- 4.4.4. Design Tool
- 4.4.4.1. Design Tool Market, 2018 - 2030 (USD Million)
- 4.4.5. Antibodies
- 4.4.5.1. Antibodies Market, 2018 - 2030 (USD Million)
- 4.4.6. Others
- 4.4.6.1. Other Products Market, 2018 - 2030 (USD Million)
- 4.5. Services
- 4.5.1. Services Market, 2018 - 2030 (USD Million)
- 4.5.2. Cell Line Engineering
- 4.5.2.1. Cell Line Engineering Market, 2018 - 2030 (USD Million)
- 4.5.3. gRNA Design & Synthesis
- 4.5.3.1. gRNA Design & Synthesis Market, 2018 - 2030 (USD Million)
- 4.5.4. Screening Services
- 4.5.4.1. Screening Services Market, 2018 - 2030 (USD Million)
- 4.5.5. Others
- 4.5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
- 5.1. Application Segment Dashboard
- 5.2. Global CRISPR And CAS Genes Market: Application Movement Analysis
- 5.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Biomedical
- 5.4.1. Biomedical Market, 2018 - 2030 (USD Million)
- 5.4.2. Genome Engineering
- 5.4.2.1. Genome Engineering Market, 2018 - 2030 (USD Million)
- 5.4.3. Disease Model Studies
- 5.4.3.1. Disease Model Studies Market, 2018 - 2030 (USD Million)
- 5.4.4. Functional Genomics
- 5.4.4.1. Functional Genomics Market, 2018 - 2030 (USD Million)
- 5.4.5. Epigenetics
- 5.4.5.1. Epigenetics Market, 2018 - 2030 (USD Million)
- 5.4.6. Others
- 5.4.6.1. Other Biomedical Applications Market, 2018 - 2030 (USD Million)
- 5.5. Agricultural
- 5.5.1. Agricultural Market, 2018 - 2030 (USD Million)
Chapter 6. End Use Business Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Global CRISPR And CAS Genes Market: End Use Movement Analysis
- 6.3. Global CRISPR And CAS Genes Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Biotechnology & Pharmaceutical Companies
- 6.4.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
- 6.5. Academic & Government Research Institutes
- 6.5.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
- 6.6. Contract Research Organizations (CROs)
- 6.6.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. North America CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. CRISPR And CAS Genes Market, 2018 - 2030 (USD MILLION)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Mexico CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Europe CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Germany CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.3. UK
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. UK CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. South Korea CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Australia CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Thailand CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Argentina CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. MEA CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Saudi Arabia CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. UAE CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait CRISPR And CAS Genes Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. Thermo Fisher Scientific
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.1.3. Product/Service Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Illumina
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.2.3. Product/Service Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Agilent Technologies
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.3.3. Product/Service Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Synthego
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.4.3. Product/Service Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Danaher
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.5.3. Product/Service Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Origene Technologies
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.6.3. Product/Service Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. GenScript
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.7.3. Product/Service Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Lonza
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.8.3. Product/Service Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Revvity, Inc.
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.9.3. Product/Service Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Merck KGaA
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.10.3. Product/Service Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.1. Thermo Fisher Scientific
